Menu
+
+
+
+
+
+
Sirenas LLC (San Diego, Calif.) and Bristol-Myers Squibb Co. (NYSE:BMY) partnered to use Sirenas' ATLANTIS drug discovery platform against several undisclosed "challenging" targets.
ATLANTIS uses machine learning to discover microbiome-derived metabolites,...
BioCentury employs a fully integrated multimedia platform — including publications, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.
